In GIST, CTHRC1 appears to activate the Wnt/PCP pathway in a dose-dependent manner, and Wnt5a/PCP-Rho axis determines the tumor invasion-promoting activity of CTHRC1 [93]. Here, CTHRC1 is linked to gastrointestinal stromal tumor.